Molecular Partners Ag (MOLN) Current Deferred Revenue (2020 - 2024)
Molecular Partners Ag's Current Deferred Revenue was $651,071 in Q2 2024, down 58.8% from $1.58 million a year earlier and down 69.2% from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Current Deferred Revenue (2020 - 2024) Analysis & Trends
At the end of FY2023, Current Deferred Revenue at Molecular Partners Ag came in at $5.14 million, up 30.4% from FY2022.
- Current Deferred Revenue shows a three-year compound annual growth rate of 15.5% (FY2020 to FY2023).
- In earlier years, Current Deferred Revenue was $3.94 million in FY2022 (-48.0%), $7.58 million in FY2021 (+127.3%) and $3.33 million in FY2020.
- The Q2 2024 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2020.
- Compared with a year earlier, Current Deferred Revenue was higher in three of the last seven quarters, with growth averaging 20.8%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q3 2022 (growth of 280.9%); the worst was Q1 2023 (a decline of 88.1%).
- Per Business Quant data, MOLN's Current Deferred Revenue in the three quarters before Q2 2024 was $2.12 million (Q1 2024), $5.14 million (Q4 2023) and $917,180 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Molecular Partners Ag | 125.16 Mn | -243.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 651,070.64 |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 5.14 Mn |
| Sep 30, 2023 | 917,180.47 |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 3.94 Mn |
| Sep 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 8.49 Mn |
| Dec 31, 2021 | 7.58 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Dec 31, 2020 | 3.33 Mn |
API Access
Molecular Partners Ag Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();